A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Part of paid clinical trials in Anchorage, Alaska.
- Sponsor
- Eli Lilly and Company
- Study ID
- NCT07174336
- Phase
- PHASE3
- Status
- Recruiting
Conditions
- Breast Neoplasms
- Neoplasm Metastasis
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- LY4064809 — DRUGAdministered orally
- Placebo — DRUGAdministered orally
- Ribociclib — DRUGAdministered orally
- Palbociclib — DRUGAdministered orally
- Abemaciclib — DRUGAdministered orally
- Anastrozole — DRUGAdministered orally
- Letrozole — DRUGAdministered orally
- Exemestane — DRUGAdministered orally
- Fulvestrant — DRUGAdministered intramuscular
Study Details
The purpose of the study is to assess the efficacy and safety of the addition of Tersolisib (LY4064809/STX-478) to other anti-cancer drugs as first treatment for advanced hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) breast cancer. Participants can remain in the study as long as the drug is helping the cancer without unbearable side effects.
Key Dates
- Start date
- Dec 22, 2025
- Status verified
- Jun 2026
- Primary completion
- May 31, 2029
- Completion
- May 31, 2033
Study Design
- Enrollment
- 920 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: LY4064809 + CDK4/6 Inhibitor + Endocrine Therapy (ET) (Part 1)LY4064809 given orally in one of two doses in combination with investigator's choice of CDK4/6 inhibitor given orally and ET given orally or intramuscularly
- Experimental: LY4064809 + CDK4/6 Inhibitor + Endocrine Therapy (ET) (Part 2)LY4064809 given orally in combination with CDK4/6 inhibitor given orally and ET given orally or intramuscularly
- Placebo Comparator: Placebo + CDK4/6 Inhibitor + Endocrine Therapy (ET) (Part 2)Placebo given orally in combination with CDK4/6 inhibitor given orally and ET given orally or intramuscularly
Primary Outcome Measure
(Part 1): Overall Response Rate (ORR): Percentage of Participants with Confirmed Complete Response (CR) or Partial Response (PR) [ Time Frame: Baseline through disease progression or death (Estimated up to 5 years) ]
Central Contacts
- Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or1-317-615-4559
- Physicians interested in becoming principal investigators please contact
Locations (117)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Alaska Oncology and Hematology | Anchorage | Alaska | 99508 | 907-257-9851 Steven Liu (PRINCIPAL_INVESTIGATOR) |
| Ironwood Cancer & Research Centers | Chandler | Arizona | 85224 | Jasleen Khanuja (PRINCIPAL_INVESTIGATOR) |
| Mayo Clinic in Arizona - Phoenix | Phoenix | Arizona | 85054 | 480-301-8000 Shakeela Bahadur (PRINCIPAL_INVESTIGATOR) |
| The University of Arizona Cancer Center - North Campus | Tucson | Arizona | 85719 | Sima Ehsani (PRINCIPAL_INVESTIGATOR) |
| Genesis Cancer and Blood Institute | Hot Springs | Arkansas | 71913 | 501-624-7700 Stephen Divers (PRINCIPAL_INVESTIGATOR) |
| Highlands Oncology Group | Springdale | Arkansas | 72762 | 479-872-8130 Joseph Beck (PRINCIPAL_INVESTIGATOR) |
| Community Cancer Institute | Clovis | California | 93611 | Li Ge (PRINCIPAL_INVESTIGATOR) |
| City of Hope | Duarte | California | 91010 | Hope Rugo (PRINCIPAL_INVESTIGATOR) |
| Marin Cancer Care | Greenbrae | California | 94904 | Cyrus Mazidi (PRINCIPAL_INVESTIGATOR) |
| Chao Family Comprehensive Cancer Center and Ambulatory Care (CIACC) - Irvine | Irvine | California | 92612 | 714-456-8614 Ritesh Parajuli (PRINCIPAL_INVESTIGATOR) |
| City of Hope Orange County Lennar Foundation Cancer Center | Irvine | California | 92618 | Hope Rugo (PRINCIPAL_INVESTIGATOR) |
| Moores Cancer Center | La Jolla | California | 92093 | Xiaojie Zhang (PRINCIPAL_INVESTIGATOR) |
| USC/Norris Comprehensive Cancer Center | Los Angeles | California | 90033 | 323-397-5954 Daphne Stewart (PRINCIPAL_INVESTIGATOR) |
| Hoag Memorial Hospital Presbyterian | Newport Beach | California | 92663 | Chaitali Nangia (PRINCIPAL_INVESTIGATOR) |
| Kaiser Permanente Oakland | Oakland | California | 94611 | 707-651-5213 Jennifer Suga (PRINCIPAL_INVESTIGATOR) |
| Profound Research LLC | Oceanside | California | 92056 | Catherine Quinn (PRINCIPAL_INVESTIGATOR) |
| University of California, Irvine (UCI) Health - UC Irvine Medical Center | Orange | California | 92868 | 714-456-8614 Ritesh Parajuli (PRINCIPAL_INVESTIGATOR) |
| Desert Regional Medical Center | Palm Springs | California | 92262 | 760-416-4749 Kim Phan (PRINCIPAL_INVESTIGATOR) |
| Stanford Cancer Center | Palo Alto | California | 94304 | Fauzia Riaz (PRINCIPAL_INVESTIGATOR) |
| Kaiser Permanente | Roseville | California | 95661 | Jennifer Suga (PRINCIPAL_INVESTIGATOR) |
| Kaiser Permanente | San Francisco | California | 94115 | 707-651-5213 Jennifer Suga (PRINCIPAL_INVESTIGATOR) |
| UCSF Medical Center at Mission Bay | San Francisco | California | 94158 | - |
| Kaiser Permanente | Santa Clara | California | 95051 | Jennifer Suga (PRINCIPAL_INVESTIGATOR) |
| UCLA Hematology/Oncology - Parkside | Santa Monica | California | 90404 | 310-998-4747 Nicholas McAndrew (PRINCIPAL_INVESTIGATOR) |
| Providence Medical Foundation | Santa Rosa | California | 95403 | Ian Anderson (PRINCIPAL_INVESTIGATOR) |
| Kaiser Permanente | Vallejo | California | 94589 | Jennifer Suga (PRINCIPAL_INVESTIGATOR) |
| Kaiser Permanente Walnut Creek | Walnut Creek | California | 94596 | 707-651-2797 Jennifer Suga (PRINCIPAL_INVESTIGATOR) |
| Cancer Centers of Colorado St. Mary's Regional Hospital | Grand Junction | Colorado | 81501 | 970-298-7500 Alicia Swink (PRINCIPAL_INVESTIGATOR) |
| Banner MD Anderson Cancer Center at North Colorado Medical Center | Greeley | Colorado | 80631 | 970-810-3894 Esther Mondo (PRINCIPAL_INVESTIGATOR) |
| Banner MD Anderson Cancer Center at McKee Medical Center | Loveland | Colorado | 80538 | 970-810-3894 Esther Mondo (PRINCIPAL_INVESTIGATOR) |
| MedStar Washington Hospital Center | Washington D.C. | District of Columbia | 20010 | Ami Chitalia (PRINCIPAL_INVESTIGATOR) |
| AdventHealth Altamonte Springs | Altamonte Springs | Florida | 32701 | Wassim Mchayleh (PRINCIPAL_INVESTIGATOR) |
| Clermont Oncology Center | Clermont | Florida | 34711 | 352-242-1366 Gopal Kunta (PRINCIPAL_INVESTIGATOR) |
| Florida Oncology & Hematology | Fort Myers | Florida | 33912 | 239-264-7026 Venkata Parsa (PRINCIPAL_INVESTIGATOR) |
| Mayo Clinic in Florida | Jacksonville | Florida | 32224 | 904-953-2000 Rishitha Bollam (PRINCIPAL_INVESTIGATOR) |
| University of Miami Hospital and Clinics, Sylvester Cancer Center | Miami | Florida | 33136 | Frances Valdes (PRINCIPAL_INVESTIGATOR) |
| Mid Florida Hematology and Oncology Center | Orange City | Florida | 32763 | 386-774-1223 Santosh Nair (PRINCIPAL_INVESTIGATOR) |
| Moffitt Cancer Center, Richard M. Shulze Family Foundation Outpatient Center | Tampa | Florida | 33612 | Aixa Soyano (PRINCIPAL_INVESTIGATOR) |
| Central Georgia Cancer Care | Macon | Georgia | 31210 | 478-336-5708 Bradley Sumrall (PRINCIPAL_INVESTIGATOR) |
| City of Hope National Medical Center, Atlanta Cancer Center | Newnan | Georgia | 30265 | Sarah Friend (PRINCIPAL_INVESTIGATOR) |
| Summit Cancer Care, PC | Savannah | Georgia | 31405 | 912-651-5771 Alison Spellman (PRINCIPAL_INVESTIGATOR) |
| Kaiser Permanente Moanalua Medical Center | Honolulu | Hawaii | 96819 | 808-432-8000 Jennifer Carney (PRINCIPAL_INVESTIGATOR) |
| City of Hope, Chicago | Chicago | Illinois | 60611 | Ajaz M. Khan (PRINCIPAL_INVESTIGATOR) |
| Northwestern Memorial Hospital | Chicago | Illinois | 60611 | William Gradishar (PRINCIPAL_INVESTIGATOR) |
| University of Illinois at Chicago | Chicago | Illinois | 60612 | 312-996-1581 Vijayakrishna Gadi (PRINCIPAL_INVESTIGATOR) |
| Accellacare of Duly | Lisle | Illinois | 60532 | Daniel Frank (PRINCIPAL_INVESTIGATOR) |
| Simmons Cancer Institute at SIU | Springfield | Illinois | 62702 | 217-545-8000 Krishna Rao (PRINCIPAL_INVESTIGATOR) |
| Indiana University Health University Hospital | Indianapolis | Indiana | 46202 | Tarah Ballinger (PRINCIPAL_INVESTIGATOR) |
| Deaconess Chancellor Center for Oncology | Newburgh | Indiana | 47630 | Karim Anwar (PRINCIPAL_INVESTIGATOR) |
| University of Iowa | Iowa City | Iowa | 52242 | 319-353-6665 Mark Burkard (PRINCIPAL_INVESTIGATOR) |
| Saint Elizabeth Medical Center Edgewood | Edgewood | Kentucky | 41017 | Matthew Kurian (PRINCIPAL_INVESTIGATOR) |
| Our Lady of the Lake RMC | Baton Rouge | Louisiana | 70808 | Marshall Stagg (PRINCIPAL_INVESTIGATOR) |
| New England Cancer Specialists | Westbrook | Maine | 04092 | Eleni Nackos (PRINCIPAL_INVESTIGATOR) |
| American Oncology Partners, PA | Bethesda | Maryland | 20817 | 301-571-2016 Victor Priego (PRINCIPAL_INVESTIGATOR) |
| James M Stockman Cancer Institute | Frederick | Maryland | 21702 | Natalia Marina (PRINCIPAL_INVESTIGATOR) |
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02215 | 617-632-3800 Antonio Giordano (PRINCIPAL_INVESTIGATOR) |
| Mass General Cancer Center | Boston | Massachusetts | 02114 | Dejan Juric (PRINCIPAL_INVESTIGATOR) |
| Dana-Farber/Brigham and Women's Cancer Center at Milford Regional Medical Center | Milford | Massachusetts | 01757 | 508-488-3700 Natalie Sinclair (PRINCIPAL_INVESTIGATOR) |
| Dana-Farber/Brigham and Women's Cancer Center - South Shore Hospital | South Weymouth | Massachusetts | 02190 | James Stoeckle (PRINCIPAL_INVESTIGATOR) |
| University of Massachusetts Medical School | Worcester | Massachusetts | 01655 | 508-856-3216 Madhavi Toke (PRINCIPAL_INVESTIGATOR) |
| Profound Research LLC | Sterling Heights | Michigan | 48314 | Laura Kohler (PRINCIPAL_INVESTIGATOR) |
| Mayo Clinic in Rochester, Minnesota | Rochester | Minnesota | 55905 | 507-284-2511 Matthew Goetz (PRINCIPAL_INVESTIGATOR) |
| North Mississippi Hematology and Oncology Associates | Tupelo | Mississippi | 38801 | Rana Usman (PRINCIPAL_INVESTIGATOR) |
| Saint Luke's Cancer Institute | Kansas City | Missouri | 64111 | 816-932-2677 Timothy Pluard (PRINCIPAL_INVESTIGATOR) |
| Oncology Hematology Associates | Springfield | Missouri | 65807 | 417-882-4880 Viran Holden (PRINCIPAL_INVESTIGATOR) |
| Dartmouth-Hitchcock Medical Center | Lebanon | New Hampshire | 03756 | Muhammad Afzal (PRINCIPAL_INVESTIGATOR) |
| Jefferson Health - Cherry Hill | Cherry Hill | New Jersey | 08002 | Steven Manobianco (PRINCIPAL_INVESTIGATOR) |
| Sidney Kimmel Cancer Center - Washington Township | Sewell | New Jersey | 08080 | Steven Manobianco (PRINCIPAL_INVESTIGATOR) |
| Atlantic Health System Overlook Medical Center | Summit | New Jersey | 07901 | Bonni Guerin (PRINCIPAL_INVESTIGATOR) |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | 646-888-5157 Komal Jhaveri (PRINCIPAL_INVESTIGATOR) |
| Messino Cancer Centers | Asheville | North Carolina | 28806 | Rachel Raab (PRINCIPAL_INVESTIGATOR) |
| WakeMed Cancer Care - Waverly Hematology & Medical Oncology | Cary | North Carolina | 27518 | 919-350-2873 Pallavi Kopparthy (PRINCIPAL_INVESTIGATOR) |
| University of North Carolina Medical Center | Chapel Hill | North Carolina | 27599 | 919-260-4616 Elizabeth Dees (PRINCIPAL_INVESTIGATOR) |
| Carolina Cancer Research Center | Wilson | North Carolina | 27893 | Keith Lerro (PRINCIPAL_INVESTIGATOR) |
| Sanford Fargo Medical Center | Fargo | North Dakota | 58102 | Anu Gaba (PRINCIPAL_INVESTIGATOR) |
| Cleveland Clinic Akron General | Akron | Ohio | 44302 | 330-888-4000 Daniel Silbiger (PRINCIPAL_INVESTIGATOR) |
| Gabrail Cancer Center | Canton | Ohio | 44718 | 330-492-3345 Nashat Gabrail (PRINCIPAL_INVESTIGATOR) |
| Fairview Hospital | Cleveland | Ohio | 44111 | 330-888-4000 Daniel Silbiger (PRINCIPAL_INVESTIGATOR) |
| The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T | Columbus | Ohio | 43210 | 614-366-1525 Robert Wesolowski (PRINCIPAL_INVESTIGATOR) |
| Cleveland Clinic - Hillcrest Hospital | Mayfield Heights | Ohio | 44124 | 330-888-4000 Daniel Silbiger (PRINCIPAL_INVESTIGATOR) |
| Good Samaritan Regional Medical Center | Corvallis | Oregon | 97330 | John Strother (PRINCIPAL_INVESTIGATOR) |
| Oncology Associates of Oregon | Eugene | Oregon | 97401 | Miho Dougherty (PRINCIPAL_INVESTIGATOR) |
| Oregon Health and Science University | Portland | Oregon | 97239 | 971-262-9600 Annie Hung (PRINCIPAL_INVESTIGATOR) |
| St. Luke's University Health Network | Bethlehem | Pennsylvania | 18015 | Maria Hafez (PRINCIPAL_INVESTIGATOR) |
| Lancaster General Hospital - Ann B Barshinger Cancer Institute | Lancaster | Pennsylvania | 17601 | Amy Clark (PRINCIPAL_INVESTIGATOR) |
| Jefferson Hospital Northeast | Philadelphia | Pennsylvania | 19114 | Steven Manobianco (PRINCIPAL_INVESTIGATOR) |
| Thomas Jefferson University - Clinical Research Institute | Philadelphia | Pennsylvania | 19107 | Steven Manobianco (PRINCIPAL_INVESTIGATOR) |
| University of Pennsylvania Hospital | Philadelphia | Pennsylvania | 19104 | Amy Clark (PRINCIPAL_INVESTIGATOR) |
| Asplundh Cancer Pavilion | Willow Grove | Pennsylvania | 19090 | Steven Manobianco (PRINCIPAL_INVESTIGATOR) |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | 843-792-9300 Abirami Sivapiragasam (PRINCIPAL_INVESTIGATOR) |
| Nashville General Hospital | Nashville | Tennessee | 37208 | 615-341-4383 Robin Jacob (PRINCIPAL_INVESTIGATOR) |
| Sarah Cannon Research Institute SCRI | Nashville | Tennessee | 37203 | SMO Sarah Cannon Research Inst. (PRINCIPAL_INVESTIGATOR) |
| Hendrick Medical Center | Abilene | Texas | 79601 | 325-670-7724 Jose Velasco Di Domenico (PRINCIPAL_INVESTIGATOR) |
| World Research Link | Baytown | Texas | 77521 | 833-832-8328 Amir Rasheed (PRINCIPAL_INVESTIGATOR) |
| Parkland Health and Hospital System | Dallas | Texas | 75235 | 214-648-4180 Nisha Unni (PRINCIPAL_INVESTIGATOR) |
| USO - Texas Oncology | Dallas | Texas | 75246 | Joyce O'Shaughnessy (PRINCIPAL_INVESTIGATOR) |
| UT Southwestern Medical Center | Dallas | Texas | 75390 | 214-648-4180 Nisha Unni (PRINCIPAL_INVESTIGATOR) |
| Texas Oncology - West Texas | El Paso | Texas | 79902 | Ines Sanchez (PRINCIPAL_INVESTIGATOR) |
| Houston Methodist Hospital | Houston | Texas | 77030 | Hanh Mai (PRINCIPAL_INVESTIGATOR) |
| Oncology Consultants P.A. | Houston | Texas | 77030 | 713-600-0900 Ricardo Alvarez (PRINCIPAL_INVESTIGATOR) |
| The University of Texas MD Anderson Cancer Center | Houston | Texas | 77030-4009 | 832-728-7423 Senthil Damodaran (PRINCIPAL_INVESTIGATOR) |
| Nova Oncology | McAllen | Texas | 78504 | 281-944-3610 Raghad Muhsin Abdul Karim, MD (PRINCIPAL_INVESTIGATOR) |
| Texas Oncology - San Antonio Medical Center | San Antonio | Texas | 78240 | Emmalind Aponte (PRINCIPAL_INVESTIGATOR) |
| US Oncology Research Network | The Woodlands | Texas | 77380 | SMO Sarah Cannon Research Inst. (PRINCIPAL_INVESTIGATOR) |
| Tranquility Research | Webster | Texas | 77598 | John Knecht (PRINCIPAL_INVESTIGATOR) |
| Utah Cancer Specialists | Salt Lake City | Utah | 84106 | Stephan Kendall (PRINCIPAL_INVESTIGATOR) |
| The University of Vermont Medical Center Inc. | Burlington | Vermont | 05405 | Peter Kaufman (PRINCIPAL_INVESTIGATOR) |
| Virginia Cancer Specialists | Fairfax | Virginia | 22031 | Shruti Tiwari (PRINCIPAL_INVESTIGATOR) |
| Swedish Cancer Institute - Edmonds | Edmonds | Washington | 98026 | Michaela Tsai (PRINCIPAL_INVESTIGATOR) |
| Providence Regional Cancer Partnership | Everett | Washington | 98201 | Xiaowen Wang (PRINCIPAL_INVESTIGATOR) |
| UW Medicine Valley Medical Center | Renton | Washington | 98055 | 425-690-3503 Navanshu Arora (PRINCIPAL_INVESTIGATOR) |
| Swedish Medical Center | Seattle | Washington | 98104 | Michaela Tsai (PRINCIPAL_INVESTIGATOR) |
| Deaconess Hospital | Spokane | Washington | 99204 | Blair Irwin (PRINCIPAL_INVESTIGATOR) |
| Cancer Care Northwest - Vercler | Spokane Valley | Washington | 99216 | Saritha Thumma (PRINCIPAL_INVESTIGATOR) |
| MultiCare Health System | Tacoma | Washington | 98405 | Blair Irwin (PRINCIPAL_INVESTIGATOR) |
| North Star Lodge | Yakima | Washington | 98902 | Blair Irwin (PRINCIPAL_INVESTIGATOR) |
| ThedaCare Physicians - Appleton North | Appleton | Wisconsin | 54911 | 920-364-3600 Shannon Schmidt (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Anchorage, AK
By condition
By specialty
By research site
Related Studies
- Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer CellsRecruiting · Washington University School of Medicine · St Louis, Missouri
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerPHASE2 · Recruiting · QuantumLeap Healthcare Collaborative · Birmingham, Alabama
- Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence ScorePHASE2 · Recruiting · Washington University School of Medicine · St Louis, Missouri
- A Registry Study of Breast Microseed TreatmentRecruiting · Concure Oncology-Breast Microseed Inc. · Pittsburgh, Pennsylvania